研究单位：[1]Eli Lilly and Company[2]First People's Hospital of Yunnan Province Kunming,Yunnan,China,650034[3]Peking Union Medical College Hospital Beijing,China,88798[4]Shanghai Putuo District Center Hospital Shanghai,China,200062[5]The First Affiliated Hospital with Nanjing Medical Universit Nanjing,Nanjing,China,210029[6]Dalian Med. Univ. No 2 Affiliate Hospital Dalian,Liao Ning,China,116023[7]No.2 Hospital Affiliated to Jilin University Changchun City,Jilin,China,130041
The purpose of this study is to compare long-acting basal insulin analog LY2963016 to Lantus® in combination with mealtime insulin lispro in adult Chinese participants with Type 1 Diabetes Mellitus (T1DM).
